Evidence map›Paper›PMID 39844590›Full record

ArticleAmerican journal of epidemiology2026

High-dimensional multiple imputation for partially observed confounders including natural language processing-derived auxiliary covariates.

Janick Weberpals, Pamela A Shaw, Kueiyu Joshua Lin, Richard Wyss, Joseph M Plasek, Li Zhou, Kerry Ngan, Thomas DeRamus, Sudha R Raman, Bradley G Hammill and 10 more

Abstract read
In one paragraph

Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Janick WeberpalsDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.ORCID 0000-0003-0404-7394
Pamela A ShawBiostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0003-1883-8410
Kueiyu Joshua LinDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Richard WyssDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Joseph M PlasekDivision of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.ORCID 0000-0002-9686-3876
Li ZhouDivision of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Kerry NganDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Thomas DeRamusDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Sudha R RamanDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0001-8659-189X
Bradley G HammillDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0002-0389-6434
Hana LeeOffice of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
Sengwee TohDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States.
John G ConnollyDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States.ORCID 0000-0003-1916-557X
Kimberly J DandreoDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, United States.
Fang TianOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.ORCID 0000-0002-7272-6199
Wei LiuOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.ORCID 0000-0002-0434-4674
Jie LiOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
José J Hernández-MuñozOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.ORCID 0000-0002-2553-3159
Sebastian SchneeweissDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.ORCID 0000-0003-2575-467X
Rishi J DesaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.ORCID 0000-0003-0299-7273

Funding

Randomized Cardiovascular Trials Duplicated Using Prospective Longitudinal Insurance Claims: Applying Techniques of Epidemiology (RCT DUPLICATE)R01HL141505 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SCHNEEWEISS, SEBASTIAN G., WANG, SHIRLEY · 2019 to 2023
$3.6M
Developing scalable algorithms to incorporate unstructured electronic health records for causal inference based on real-world dataR01LM013204 · NLM · BRIGHAM AND WOMEN'S HOSPITAL · PI LIN, JOSHUA K · 2020 to 2024
$2.7M
FDA HHS 75F40119F19002Master Agreement 75F40119D10037NHLBI NIH HHS R01 HL141505NIH HHS RO1LM013204NLM NIH HHS R01 LM013204
6 · The paper itself

Abstract

Multiple imputation (MI) models can be improved with auxiliary covariates (ACs), but their performance in high-dimensional data remains unclear. We aimed to develop and compare high-dimensional MI (HDMI) methods using structured and natural language processing (NLP)-derived AC in studies with partially observed confounders. We conducted a plasmode simulation with acute kidney injury as outcome and simulated 100 cohorts with a null treatment effect, incorporating creatinine labs, atrial fibrillation (AFib), and other investigator-derived confounders in the outcome generation. Missingness was imposed on creatinine based on creatinine itself and AFib. Different HDMI candidate ACs were created using structured and NLP-derived features, and we mimicked scenarios where AFib was unobserved by omitting it from all analyses. Using the least absolute shrinkage and selection operator, we selected HDMI covariates for MI and propensity score models. The treatment effect was estimated after propensity score matching in MI datasets, and HDMI methods were compared to baseline imputation and complete case analysis. High-dimensional MI using claims data showed the lowest bias (0.072). Combining claims and sentence embeddings led to an improvement in the efficiency with a root mean square error (RMSE) of 0.173 and 94% coverage. Natural language processing-derived AC alone did not outperform baseline MI. High-dimensional MI approaches may decrease bias in studies where confounder missingness depends on unobserved factors.

Indexed as

Acute Kidney InjuryModels, StatisticalNatural Language ProcessingAtrial FibrillationBiasComputer SimulationConfounding Factors, EpidemiologicCreatinineData Interpretation, StatisticalHumansPropensity ScoreCreatinineconfoundingEHRmissing dataNLPreal-world evidence

Identifiers

PMID39844590
PMCPMC12780782

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.